Moreover, the association of overexpression of RBM4 with Mcl-1 exon 2 and intron 2 shifted Mcl-1L to Mcl-1S transcripts, which, in part, deprived breast cancer cells of apoptotic resistance against chemotherapeutic treatment [131]. This evidence concerns the gene RBM4 and breast carcinoma.